Feasibility and safety of autologous intracoronary stem cell transplantation in patients of non ischemic dilated cardiomyopathy

Indian Heart Journal

Volumn 59, Issue 6, 2007, Pages 511-514

  Nair, Mohan ^a   Mukherjee, S ^a   Ahluwalia, N S ^a   Vaid, A K ^b   Kumar, Neeraj ^b  

^a ST STEPHEN S HOSPITAL   (India)

^b Department of Oncology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CALCIUM; CARVEDILOL; CLOPIDOGREL; CREATINE KINASE MB; DIGOXIN; ELECTROLYTE; ENOXAPARIN; FUROSEMIDE; GLYCERYL TRINITRATE; GRANULOCYTE COLONY STIMULATING FACTOR; RAMIPRIL; SPIRONOLACTONE;

ADULT; BONE PAIN; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY; CORONARY ARTERY SPASM; DRUG HYPERSENSITIVITY; ECHOCARDIOGRAPHY; ELECTROLYTE BLOOD LEVEL; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOLOGY; HOLTER MONITORING; HOSPITALIZATION; HUMAN; HYPOTENSION; KIDNEY FUNCTION TEST; LETTER; LEUKAPHERESIS; MALE; NEUTROPHIL COUNT; ST SEGMENT ELEVATION; STEM CELL TRANSPLANTATION; THORAX PAIN; THORAX RADIOGRAPHY;

ADULT; CARDIOMYOPATHY, DILATED; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 56449089809     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Letter

References (18)

1. Taylor DA. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease. Curr Control Trials Cardiovasc Medicine 2001;2:208-210.
2. Hagege AA, Vilquin JT, Bruneval P, et al. Regeneration of the myocardium: a new role in treatment of ischemic heart disease? Hypertension 2001;38:1413-1415.
3. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-280.
4. Reinecke H, MacDonald GH, Hauschka SD, et al. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 2000;149:731-740.
5. Reinecke H, Poppa V, Murry C. Skeletal muscle stem cell do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241-249.
6. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000;100:157-168.
7. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell 2001;105:829-841.
8. Stamn C, Westphal B, Kleine KD, et al. Bone marrow transplantation for myocardial regeneration in post infarction CABG patients. Circulation 2002;106(suppl II);II-375.
9. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705.
10. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918.
11. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infracted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-10349.
12. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration regeneration enhancement in acute myocardial infarction. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002;106:3009-3017.
13. Minatoguchi S, Takemura G, Chen X, et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by post infarction granulocyte colony stimulating factor treatment. Circulation 2004;109:2572-2580.
14. Hassink RJ, Mummery CL, de la Riviere AB. Transplantation of cells for cardiac repair. JACC 2003;41:711-717.
15. Siminiak T, Kurpisz M. Myocardial replacement therapy. Circulation 2003;108:1167-1171.
16. Forrester JS, Price MJ, Makkar RR. Stem cell repair of infracted myocardium; an overview for clinicians. Circulation 2003;108:1139-1145.
17. Fuchs S, Weisz G, Kornowski R, et al. Catheter based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility and safety study. Circulation 2002;106(suppl II);II-655-II-656.
18. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-545.